Cargando…

Iron Heterogeneity in Early Active Multiple Sclerosis Lesions

OBJECTIVE: Multiple sclerosis (MS) is a heterogeneous inflammatory demyelinating disease. Iron distribution is altered in MS patients' brains, suggesting iron liberation within active lesions amplifies demyelination and neurodegeneration. Whether the amount and distribution of iron are similar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tham, Mylyne, Frischer, Josa M., Weigand, Stephen D., Fitz‐Gibbon, Patrick D., Webb, Samuel M., Guo, Yong, Adiele, Reginald C., Robinson, Christopher A., Brück, Wolfgang, Lassmann, Hans, Furber, Kendra L., Pushie, M. Jake, Parisi, Joseph E., Lucchinetti, Claudia F., Popescu, Bogdan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986227/
https://www.ncbi.nlm.nih.gov/pubmed/33244761
http://dx.doi.org/10.1002/ana.25974
_version_ 1783668404009304064
author Tham, Mylyne
Frischer, Josa M.
Weigand, Stephen D.
Fitz‐Gibbon, Patrick D.
Webb, Samuel M.
Guo, Yong
Adiele, Reginald C.
Robinson, Christopher A.
Brück, Wolfgang
Lassmann, Hans
Furber, Kendra L.
Pushie, M. Jake
Parisi, Joseph E.
Lucchinetti, Claudia F.
Popescu, Bogdan F.
author_facet Tham, Mylyne
Frischer, Josa M.
Weigand, Stephen D.
Fitz‐Gibbon, Patrick D.
Webb, Samuel M.
Guo, Yong
Adiele, Reginald C.
Robinson, Christopher A.
Brück, Wolfgang
Lassmann, Hans
Furber, Kendra L.
Pushie, M. Jake
Parisi, Joseph E.
Lucchinetti, Claudia F.
Popescu, Bogdan F.
author_sort Tham, Mylyne
collection PubMed
description OBJECTIVE: Multiple sclerosis (MS) is a heterogeneous inflammatory demyelinating disease. Iron distribution is altered in MS patients' brains, suggesting iron liberation within active lesions amplifies demyelination and neurodegeneration. Whether the amount and distribution of iron are similar or different among different MS immunopatterns is currently unknown. METHODS: We used synchrotron X‐ray fluorescence imaging, histology, and immunohistochemistry to compare the iron quantity and distribution between immunopattern II and III early active MS lesions. We analyzed archival autopsy and biopsy tissue from 21 MS patients. RESULTS: Immunopattern II early active lesions contain 64% more iron (95% confidence interval [CI] = 17–127%, p = 0.004) than immunopattern III lesions, and 30% more iron than the surrounding periplaque white matter (95% CI = 3–64%, p = 0.03). Iron in immunopattern III lesions is 28% lower than in the periplaque white matter (95% CI = −40 to −14%, p < 0.001). When normalizing the iron content of early active lesions to that of surrounding periplaque white matter, the ratio is significantly higher in immunopattern II (p < 0.001). Microfocused X‐ray fluorescence imaging shows that iron in immunopattern II lesions localizes to macrophages, whereas macrophages in immunopattern III lesions contain little iron. INTERPRETATION: Iron distribution and content are heterogeneous in early active MS lesions. Iron accumulates in macrophages in immunopattern II, but not immunopattern III lesions. This heterogeneity in the two most common MS immunopatterns may be explained by different macrophage polarization, origin, or different demyelination mechanisms, and paves the way for developing new or using existing iron‐sensitive magnetic resonance imaging techniques to differentiate among immunopatterns in the general nonbiopsied MS patient population. ANN NEUROL 2021;89:498–510
format Online
Article
Text
id pubmed-7986227
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-79862272021-03-25 Iron Heterogeneity in Early Active Multiple Sclerosis Lesions Tham, Mylyne Frischer, Josa M. Weigand, Stephen D. Fitz‐Gibbon, Patrick D. Webb, Samuel M. Guo, Yong Adiele, Reginald C. Robinson, Christopher A. Brück, Wolfgang Lassmann, Hans Furber, Kendra L. Pushie, M. Jake Parisi, Joseph E. Lucchinetti, Claudia F. Popescu, Bogdan F. Ann Neurol Research Articles OBJECTIVE: Multiple sclerosis (MS) is a heterogeneous inflammatory demyelinating disease. Iron distribution is altered in MS patients' brains, suggesting iron liberation within active lesions amplifies demyelination and neurodegeneration. Whether the amount and distribution of iron are similar or different among different MS immunopatterns is currently unknown. METHODS: We used synchrotron X‐ray fluorescence imaging, histology, and immunohistochemistry to compare the iron quantity and distribution between immunopattern II and III early active MS lesions. We analyzed archival autopsy and biopsy tissue from 21 MS patients. RESULTS: Immunopattern II early active lesions contain 64% more iron (95% confidence interval [CI] = 17–127%, p = 0.004) than immunopattern III lesions, and 30% more iron than the surrounding periplaque white matter (95% CI = 3–64%, p = 0.03). Iron in immunopattern III lesions is 28% lower than in the periplaque white matter (95% CI = −40 to −14%, p < 0.001). When normalizing the iron content of early active lesions to that of surrounding periplaque white matter, the ratio is significantly higher in immunopattern II (p < 0.001). Microfocused X‐ray fluorescence imaging shows that iron in immunopattern II lesions localizes to macrophages, whereas macrophages in immunopattern III lesions contain little iron. INTERPRETATION: Iron distribution and content are heterogeneous in early active MS lesions. Iron accumulates in macrophages in immunopattern II, but not immunopattern III lesions. This heterogeneity in the two most common MS immunopatterns may be explained by different macrophage polarization, origin, or different demyelination mechanisms, and paves the way for developing new or using existing iron‐sensitive magnetic resonance imaging techniques to differentiate among immunopatterns in the general nonbiopsied MS patient population. ANN NEUROL 2021;89:498–510 John Wiley & Sons, Inc. 2020-12-19 2021-03 /pmc/articles/PMC7986227/ /pubmed/33244761 http://dx.doi.org/10.1002/ana.25974 Text en © 2020 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Tham, Mylyne
Frischer, Josa M.
Weigand, Stephen D.
Fitz‐Gibbon, Patrick D.
Webb, Samuel M.
Guo, Yong
Adiele, Reginald C.
Robinson, Christopher A.
Brück, Wolfgang
Lassmann, Hans
Furber, Kendra L.
Pushie, M. Jake
Parisi, Joseph E.
Lucchinetti, Claudia F.
Popescu, Bogdan F.
Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title_full Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title_fullStr Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title_full_unstemmed Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title_short Iron Heterogeneity in Early Active Multiple Sclerosis Lesions
title_sort iron heterogeneity in early active multiple sclerosis lesions
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986227/
https://www.ncbi.nlm.nih.gov/pubmed/33244761
http://dx.doi.org/10.1002/ana.25974
work_keys_str_mv AT thammylyne ironheterogeneityinearlyactivemultiplesclerosislesions
AT frischerjosam ironheterogeneityinearlyactivemultiplesclerosislesions
AT weigandstephend ironheterogeneityinearlyactivemultiplesclerosislesions
AT fitzgibbonpatrickd ironheterogeneityinearlyactivemultiplesclerosislesions
AT webbsamuelm ironheterogeneityinearlyactivemultiplesclerosislesions
AT guoyong ironheterogeneityinearlyactivemultiplesclerosislesions
AT adielereginaldc ironheterogeneityinearlyactivemultiplesclerosislesions
AT robinsonchristophera ironheterogeneityinearlyactivemultiplesclerosislesions
AT bruckwolfgang ironheterogeneityinearlyactivemultiplesclerosislesions
AT lassmannhans ironheterogeneityinearlyactivemultiplesclerosislesions
AT furberkendral ironheterogeneityinearlyactivemultiplesclerosislesions
AT pushiemjake ironheterogeneityinearlyactivemultiplesclerosislesions
AT parisijosephe ironheterogeneityinearlyactivemultiplesclerosislesions
AT lucchinetticlaudiaf ironheterogeneityinearlyactivemultiplesclerosislesions
AT popescubogdanf ironheterogeneityinearlyactivemultiplesclerosislesions